Keywords: congress, bacterial vaccines, viral vaccines, animal models, pharmaceutical technology

Palabras clave: congreso, vacunas bacterianas, vacunas virales, modelos animales, tecnología farmacéutica

Carátula del artículo

Events

VacciPharma 2020. V International Congress on Pharmacology of Vaccines

Vaccipharma 2020. V Congreso Internacional sobre Farmacología de Vacunas

Mario Landys Chovel Cuervo mlandys@finlay.edu.cu

Sociedad Cubana de Farmacología, Cuba

Reinaldo Acevedo Grogues racevedo@finlay.edu.cu

Cuba

Vaccimonitor, vol. 29, no. 1, pp. 1-2, 2020
Finlay Ediciones

Received: 02 December 2019

Accepted: 04 December 2019

Dear colleagues:

The Organizing Committee of the “V International Congress on Pharmacology of Vaccines” (VacciPharma 2020) organized by the Cuban Society of Pharmacology, BioCubaFarma and the International Union of Basic and Clinical Pharmacology (IUPHAR) would like to invite you to participate in this important event, scheduled for June 14 to 18, 2020 at the Convention Centre of the Melia Marina Varadero Hotel, Varadero Beach, Matanzas, Cuba.

The Congress will be formed by different workshops and symposia such as:

• Meningococcal and Gonococcal vaccines

• Pneumococcal vaccines

• Pertussis and combined vaccines

• Enteric vaccines

• Leptospira vaccines

• Viral vaccines

• Animal models in vaccine development, QC and 3Rs

• Vaccine technology and bioprocess

• Vaccine technology transfers

• Patent, business and international cooperation

VacciPharma 2020 is sponsored by:

• Cuban Society of Pharmacology (SCF)

• International Union of Basic and Clinical Pharmacology (IUPHAR)

• Latin-American Association of Pharmacology (ALF)

• PAHO / WHO

• BioCubaFarma

• National research centers: Finlay Vaccine Institute (IFV); Center of Genetic Engineering and Biotechnology (CIGB); Center of Molecular Immunology (CIM); Center for Control of Drugs, Equipment and Medical Devices (CECMED); National Center for Animal and Plant Health (CENSA); Tropical Medicine Institute “Pedro Kourí” (IPK); National Center for Biopreparations (BioCEN); Center for Drug Research and Development (CIDEM); Center for Clinical Trials (CENCEC); among others

• International Manufacturers and Companies

The key objectives of the Congress are:

• To provide a progressive state-of-the-art report for scientists, manufacturers, governmental authorities and healthcare workers, who need to be updated about the latest scientific developments for human vaccines, including basic science, product development, market introduction, immunization programs and epidemiological surveillance.

• To promote the scientific collaboration among experts and institutions through the experience exchange, the presentation of results and the discussion on the conference topics.

• To accelerate progress in the development of vaccines and the acceptance and introduction of new methods and technologies.

Opening lectures, oral presentations and posters will provide you the opportunity to be involved in a high quality congress to discuss about the progress in the field of vaccinology and pharmacology sciences.

Deadline for registration and abstract submission: April 15^th, 2020

Further information can be found at the VacciPharma 2020

Website: www.immunovaccipharma.com

We hope to see you in VacciPharma 2020.